Constitutional Challenge Casts Shadow Over Renk's Record Orders and Dividend Hike
25.05.2026 - 07:13:03 | boerse-global.de
Renk's shares are trying to shake off a prolonged downturn, but a new legal hurdle threatens to complicate the defence contractor's reliance on fast-track Bundeswehr procurement. Germany's Higher Regional Court of DĂĽsseldorf has referred a key provision of the military procurement acceleration law to the Federal Constitutional Court in Karlsruhe. The judges argue that Section 16(1) of the act, which curbs the suspensory effect of procurement complaints, may violate the constitutional right to legal remedy under Article 19(4) of the Basic Law. For Renk, where predictable timelines on government contracts are crucial, the decision injects fresh planning risk into an already fragile technical recovery.
None of that uncertainty has dented the company's operational momentum. First-quarter figures released earlier showed order intake climbing to €582.3 million, roughly 6% above the prior-year level, while the backlog swelled to €6.9 billion at the end of March. Revenue advanced 4.0% to €283.6 million, and adjusted EBIT jumped 10.4% to €42.4 million, translating into a margin of 15%. Management reaffirmed its full-year guidance for revenue above €1.5 billion and adjusted EBIT in the range of €255 million to €285 million.
Shareholders have something to look forward to at the annual general meeting scheduled for 10 June. Renk's board is proposing a dividend of €0.58 per share, a 38% increase over the prior year, implying a payout ratio of roughly 41%. The dividend signal arrives alongside a busy conference calendar this week: the dbAccess European Champions Conference in Frankfurt on Tuesday, followed by the Erste Group CEElection Conference in Warsaw on Wednesday and Thursday. These events give management a platform to pitch the investment case built on a towering order book and exposure to the defence spending cycle.
Should investors sell immediately? Or is it worth buying Renk?
Institutional interest is also bubbling beneath the surface. FMR LLC, part of the Fidelity group, disclosed on 22 May that it had crossed the 3% reporting threshold four days earlier, now holding a 4.94% stake in Renk – roughly 4.94 million shares. Of that, Fidelity Advisor Series VIII directly controls 3.23% of voting rights. The move by a major global investor suggests that the legal noise has not deterred conviction buyers from accumulating a meaningful position at current levels.
The stock itself has clawed back from its 52-week low of €43.99, closing Friday at €49.09. That marks a 9.89% gain over the past seven days but leaves the equity still 44% below the peak struck in October 2025. Technicians are watching a resistance band between €49.98 (the 20-day moving average) and €51.64 (the 50-day line), with the 200-day average near €55 as a longer-term target. On the downside, a break back below €45.97 would revive the support zone around €40–€41. The relative strength index has climbed to 78.0, signalling that the recent bounce is already overbought, while the share price remains 17.45% beneath its 200-day average.
For now, Renk finds itself caught between a robust operational base and a regulatory overhang that could slow future Bundeswehr contract awards until Karlsruhe weighs in. The next few weeks, with the AGM and investor roadshows, offer a chance to reinforce the narrative of defence-driven growth. Whether the market buys that story depends on whether the technical recovery can survive the constitutional test.
Ad
Renk Stock: New Analysis - 25 May
Fresh Renk information released. What's the impact for investors? Our latest independent report examines recent figures and market trends.
